KR920000310A - 코팅된 수의 이식정 - Google Patents
코팅된 수의 이식정 Download PDFInfo
- Publication number
- KR920000310A KR920000310A KR1019910010205A KR910010205A KR920000310A KR 920000310 A KR920000310 A KR 920000310A KR 1019910010205 A KR1019910010205 A KR 1019910010205A KR 910010205 A KR910010205 A KR 910010205A KR 920000310 A KR920000310 A KR 920000310A
- Authority
- KR
- South Korea
- Prior art keywords
- polyvinyl alcohol
- tablet
- implantable
- somatotropin
- growth hormone
- Prior art date
Links
- 239000007943 implant Substances 0.000 title 1
- 239000004372 Polyvinyl alcohol Substances 0.000 claims abstract 16
- 229920002451 polyvinyl alcohol Polymers 0.000 claims abstract 16
- 230000000975 bioactive effect Effects 0.000 claims abstract 10
- 239000000463 material Substances 0.000 claims abstract 8
- 241001465754 Metazoa Species 0.000 claims abstract 7
- 239000008188 pellet Substances 0.000 claims abstract 6
- 230000007062 hydrolysis Effects 0.000 claims abstract 4
- 238000006460 hydrolysis reaction Methods 0.000 claims abstract 4
- 239000007864 aqueous solution Substances 0.000 claims abstract 3
- 108010006025 bovine growth hormone Proteins 0.000 claims abstract 3
- 238000007911 parenteral administration Methods 0.000 claims abstract 2
- 239000007909 solid dosage form Substances 0.000 claims abstract 2
- 238000007920 subcutaneous administration Methods 0.000 claims abstract 2
- 238000000034 method Methods 0.000 claims 20
- 108010051696 Growth Hormone Proteins 0.000 claims 12
- 102000018997 Growth Hormone Human genes 0.000 claims 12
- 239000011248 coating agent Substances 0.000 claims 9
- 239000000122 growth hormone Substances 0.000 claims 7
- 238000000576 coating method Methods 0.000 claims 5
- 241000283690 Bos taurus Species 0.000 claims 4
- 241000282898 Sus scrofa Species 0.000 claims 4
- 229910021645 metal ion Inorganic materials 0.000 claims 3
- 239000000126 substance Substances 0.000 claims 3
- 239000007787 solid Substances 0.000 claims 2
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 claims 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims 1
- 101000868144 Sus scrofa Somatotropin Proteins 0.000 claims 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 claims 1
- 229910052802 copper Inorganic materials 0.000 claims 1
- 239000010949 copper Substances 0.000 claims 1
- 235000013365 dairy product Nutrition 0.000 claims 1
- 238000009472 formulation Methods 0.000 claims 1
- 230000002401 inhibitory effect Effects 0.000 claims 1
- 239000000203 mixture Substances 0.000 claims 1
- 239000007921 spray Substances 0.000 claims 1
- 238000013268 sustained release Methods 0.000 claims 1
- 239000012730 sustained-release form Substances 0.000 claims 1
- 238000002054 transplantation Methods 0.000 claims 1
- 229920002554 vinyl polymer Polymers 0.000 claims 1
- 239000011701 zinc Substances 0.000 claims 1
- 229910052725 zinc Inorganic materials 0.000 claims 1
- 238000002513 implantation Methods 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 238000005507 spraying Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/27—Growth hormone [GH], i.e. somatotropin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Endocrinology (AREA)
- Zoology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Dermatology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Organic Chemistry (AREA)
- Reproductive Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Preparation (AREA)
- Materials For Medical Uses (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
내용 없음
Description
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음
Claims (29)
- 연장된 수송기간 동안 약효량을 제공하기에 충분한 양의 생리활성물질의 고형코어를 함유하고, 약 10,000의 분자량과 약 95%의 가수분해도를 지닌 플리비닐알코올로 이러한 코오를 둘러싸고 있는 방출저해 플리비닐알코올코팅을 함유하는 것을 특징으로 하는 서방성 수송 생리활성물질의 코팅된 수의 이식정.
- 제1항에 있어서, 상기 폴리비닐알코올 코팅제의 양의 약 0.5-5중량 퍼센트임을 특징으로 하는 이식정.
- 제1항에 있어서, 상기 폴리비닐알코올 코팅제의 양의 약 3-25㎛g/㎟임을 특징으로 하는 이식정.
- 제1항에 있어서, 상기 폴리비닐알코올 코팅은 상기 생리활성물질의 코어 표면에 대해 대체로 균일하고 연속적임을 특징으로 하는 이식정.
- 제1항에 있어서, 상기 생리활성물질은 성장호르몬임을 특징으로 하는 이식정.
- 제5항에 있어서, 상기 성장호르몬은 소나 혹은 돼지의 소마토트로핀임을 특징으로 하는 이식정.
- 제6항에 있어서, 상기 소마토트로핀을 금속이온과 결합됨을 특징으로 하는 이식정.
- 제7항에 있어서, 상기 소마트트로핀은 돼지형이고, 상기 금속이온은 구리임을 특징으로 하는 이식정.
- 제7항에 있어서, 상기 소마토트로핀은 소형이고, 상기 금속이온은 아연임을 특징으로 하는 이식정.
- 제1항에 있어서, 그 펠렛정 형태가 원통형, 난형 혹은 구형임을 특징으로 하는 이식정.
- 제1항에 있어서, 상기 폴리비닐알코올의 분자량의 약 20,000-100,000임을 특징으로 하는 이식정.
- 제11항에 있어서, 상기 폴리비닐알코올의 가수분해도는 약 98%임을 특징으로 하는 이식정.
- 분자량의 약 10,000이고 가수분해도가 약 95%인 폴리비닐알코올 층을 지닌 코팅된 재형을 포함하는 생리활성물질의 이식가능한 고체 채형을 동물에게 비경구적으로 투여함을 특징으로 하는 방출을 연장하는 방법.
- 제13항에 있어서, 상기 코팅제는 약 0.5-5중량 퍼센트의 양으로 적용됨을 특징으로 하는 방법.
- 제13항에 있어서, 상기 폴리비닐알코올 코팅제는 약 3-25㎛g/㎟의 양으로 적용됨을 특징으로 하는 방법.
- 제13항에 있어서, 상기 폴리비닐알코올 코팅은 고체 제형의 표면에 대해 대체로 균일하고 연속적임을 특징으로 하는 방법.
- 제13항에 있어서, 상기 생리활성물질은 성장호르몬임을 특징으로 하는 방법.
- 제17항에 있어서, 상기 성장호르몬은 소나 혹은 돼지의 소마토트로핀임을 특징으로 하는 방법.
- 제13항에 있어서, 상기 폴리비닐알코올 코팅제는 상기 조체 제형의 표면에 수용액으로 적용됨을 특징으로 하는 방법.
- 제19항에 있어서, 상기 수용액이 약2-10%의 폴리비닐알코올을 함유함을 특징으로 하는 방법.
- 제13항에 있어서, 상기 생리활성물질이 밀집충진된 펠렛정의 형태임을 특징으로 하는 방법.
- 제21항에 있어서, 상기 폴리비닐알코올 코팅제를 유동베드에서 분무 코팅시켜 상기 펠렛정에 적용시킴을 특징으로 하는 방법.
- 제21항에 있어서, 상기 폴리비닐알코올을 팬 건조기에서 분부 코팅시켜 상기 펠렛저에 저용시킴을 특징으로 하는 방법.
- 제21항에 있어서, 상기 펠렛점은 원통형, 구형 혹은 난형임을 특징으로 하는 방법.
- 제1항의 코팅된 수의 이식정을 상기 동물에게 비경구적으로 투여함으로써 연장된 기간동안 생리활성 물질을 동물에게 공급함을 특징으로 하는 방법.
- 제25항에 있어서, 상기 생리활성물질은 성장호르몬임을 특징으로 하는 방법.
- 제26항에 있어서, 상기 성장호르몬은 소의 소마토트로핀이고 상기 동물은 젖소 혹은 욕우임을 특징으로 하는 방법.
- 제26항에 있어서, 상기 성장호르몬은 돼지 소마토트로핀이고 상기 동물은 돼지임을 특징으로 하는 방법.
- 제25항에 있어서, 상기 비경구투여는 피하이식에 의한 것임을 특징으로 하는 방법.※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US07/541,114 US5091185A (en) | 1990-06-20 | 1990-06-20 | Coated veterinary implants |
US541,114 | 1990-06-20 |
Publications (2)
Publication Number | Publication Date |
---|---|
KR920000310A true KR920000310A (ko) | 1992-01-29 |
KR940000002B1 KR940000002B1 (ko) | 1994-01-05 |
Family
ID=24158232
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1019910010205A KR940000002B1 (ko) | 1990-06-20 | 1991-06-19 | 코팅된 수의 이식정 |
Country Status (14)
Country | Link |
---|---|
US (1) | US5091185A (ko) |
EP (1) | EP0462959B1 (ko) |
JP (1) | JPH0753659B2 (ko) |
KR (1) | KR940000002B1 (ko) |
AT (1) | ATE132745T1 (ko) |
AU (1) | AU633741B2 (ko) |
BR (1) | BR9102559A (ko) |
CA (1) | CA2044979A1 (ko) |
DE (1) | DE69116241D1 (ko) |
IE (1) | IE77161B1 (ko) |
IL (1) | IL98558A (ko) |
NZ (1) | NZ238612A (ko) |
PT (1) | PT98025A (ko) |
ZA (1) | ZA914720B (ko) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20020031241A (ko) * | 2000-10-23 | 2002-05-01 | 유종구 | 패각류를 이용한 알칼리성 칼슘 제조방법 |
Families Citing this family (38)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5156851A (en) * | 1990-06-20 | 1992-10-20 | Monsanto Company | Coated veterinary implants |
US5378475A (en) * | 1991-02-21 | 1995-01-03 | University Of Kentucky Research Foundation | Sustained release drug delivery devices |
NZ286242A (en) * | 1991-03-26 | 1997-11-24 | Csl Ltd | Use of veterinary implant as a single dose vaccination system: rupturable polymer film coating around core of active agent and water soluble excipient |
US5429822A (en) * | 1992-03-13 | 1995-07-04 | Cambridge Scientific, Inc. | Biodegradable bursting release system |
ES2107051T3 (es) * | 1992-09-21 | 1997-11-16 | Upjohn Co | Formulaciones de proteinas de liberacion sostenida. |
KR100260632B1 (ko) * | 1992-12-28 | 2000-07-01 | 성재갑 | 이식형 소마토트로핀 조성물 |
HU225496B1 (en) * | 1993-04-07 | 2007-01-29 | Scios Inc | Pharmaceutical compositions of prolonged delivery, containing peptides |
US6284727B1 (en) | 1993-04-07 | 2001-09-04 | Scios, Inc. | Prolonged delivery of peptides |
US5672357A (en) * | 1994-07-01 | 1997-09-30 | Monsanto Company | Method and device for implantation of large diameter objects in bovines |
US5595752A (en) * | 1994-07-01 | 1997-01-21 | Monsanto Company | Increasing dressing percentage and carcass weight in finishing beef cattle |
US5773019A (en) * | 1995-09-27 | 1998-06-30 | The University Of Kentucky Research Foundation | Implantable controlled release device to deliver drugs directly to an internal portion of the body |
KR100210509B1 (ko) * | 1996-01-10 | 1999-07-15 | 성재갑 | 지속성 동물 성장 호르몬 제형 및 이의 제조 방법 |
US6416778B1 (en) | 1997-01-24 | 2002-07-09 | Femmepharma | Pharmaceutical preparations and methods for their regional administration |
US5993856A (en) * | 1997-01-24 | 1999-11-30 | Femmepharma | Pharmaceutical preparations and methods for their administration |
US5902598A (en) * | 1997-08-28 | 1999-05-11 | Control Delivery Systems, Inc. | Sustained release drug delivery devices |
US6039977A (en) * | 1997-12-09 | 2000-03-21 | Alza Corporation | Pharmaceutical hydrogel formulations, and associated drug delivery devices and methods |
US6022554A (en) * | 1997-12-15 | 2000-02-08 | American Home Products Corporation | Polymeric microporous film coated subcutaneous implant |
KR19990071255A (ko) | 1998-02-28 | 1999-09-15 | 성재갑 | 소마토트로핀과 비타민의 합제 조성물 |
US20040121014A1 (en) * | 1999-03-22 | 2004-06-24 | Control Delivery Systems, Inc. | Method for treating and/or preventing retinal diseases with sustained release corticosteroids |
US6217895B1 (en) | 1999-03-22 | 2001-04-17 | Control Delivery Systems | Method for treating and/or preventing retinal diseases with sustained release corticosteroids |
US6375972B1 (en) | 2000-04-26 | 2002-04-23 | Control Delivery Systems, Inc. | Sustained release drug delivery devices, methods of use, and methods of manufacturing thereof |
US20040022853A1 (en) * | 2001-04-26 | 2004-02-05 | Control Delivery Systems, Inc. | Polymer-based, sustained release drug delivery system |
KR20040005936A (ko) * | 2001-04-26 | 2004-01-16 | 컨트롤 딜리버리 시스템즈 인코포레이티드 | 공동약물을 함유하는 서방 약물 전달 시스템 |
AUPR602401A0 (en) * | 2001-06-29 | 2001-07-26 | Smart Drug Systems Inc | Sustained release delivery system |
US20030050595A1 (en) * | 2001-09-07 | 2003-03-13 | Campbell Colin B. | Pellet implant system and method of administration |
IN2014DN10834A (ko) * | 2001-09-17 | 2015-09-04 | Psivida Inc | |
JP2005513080A (ja) * | 2001-12-20 | 2005-05-12 | フェムファーマ, インコーポレイテッド | 薬物の膣送達 |
DE10207427A1 (de) * | 2002-02-21 | 2003-09-04 | Basf Ag | Schnelllöslicher Filmüberzug basierend auf Polyvinylalkohol-Polyether-Pfropfcopolymeren in Kombination mit Hydroxy-, Amid-, oder Esterfunktionen enthaltenden Komponenten |
US8871241B2 (en) | 2002-05-07 | 2014-10-28 | Psivida Us, Inc. | Injectable sustained release delivery devices |
MXPA05007266A (es) * | 2003-01-02 | 2006-01-17 | Femmepharma Holding Co Inc | Preparaciones farmaceuticas para tratamientos de enfermedades y trastornos del seno. |
US9173836B2 (en) | 2003-01-02 | 2015-11-03 | FemmeParma Holding Company, Inc. | Pharmaceutical preparations for treatments of diseases and disorders of the breast |
PL2233112T6 (pl) * | 2003-11-13 | 2014-11-28 | Psivida Inc | Wstrzykiwalny implant o przedłużonym uwalnianiu mający biodegradowalną matrycę i biodegradowalną warstewkę |
WO2008083158A2 (en) * | 2006-12-26 | 2008-07-10 | Femmepharma Holding Company, Inc. | Topical administration of danazol |
US20110003000A1 (en) * | 2009-07-06 | 2011-01-06 | Femmepharma Holding Company, Inc. | Transvaginal Delivery of Drugs |
JP2013515741A (ja) * | 2009-12-23 | 2013-05-09 | サイヴィーダ ユーエス,インコーポレイテッド | 持続放出性送達デバイス |
CN110575445B (zh) | 2013-03-21 | 2023-08-18 | 优普顺药物公司美国分部 | 可注射的持续释放组合物及其用于治疗关节炎症及相关疼痛的方法 |
ES2672993T3 (es) * | 2015-10-27 | 2018-06-19 | Eupraxia Pharmaceuticals Inc. | Formulaciones de liberación sostenida de anestésicos locales |
US11529310B2 (en) | 2020-12-08 | 2022-12-20 | Ruminant Biotech Corp Limited | Devices and methods for delivery of substances to animals |
Family Cites Families (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU454482B2 (en) * | 1970-11-05 | 1974-10-15 | Alza Corporation | Drug-delivery system |
US4173626A (en) * | 1978-12-11 | 1979-11-06 | Merck & Co., Inc. | Sustained release indomethacin |
US4326524A (en) * | 1980-09-30 | 1982-04-27 | Minnesota Mining And Manufacturing Company | Solid dose ballistic projectile |
ATE37983T1 (de) * | 1982-04-22 | 1988-11-15 | Ici Plc | Mittel mit verzoegerter freigabe. |
JPS5956446A (ja) * | 1982-09-24 | 1984-03-31 | Nippon Oil Co Ltd | ポリビニルアルコ−ル凍結ゲルの柔軟性低下法 |
US4882167A (en) * | 1983-05-31 | 1989-11-21 | Jang Choong Gook | Dry direct compression compositions for controlled release dosage forms |
AU571922B2 (en) * | 1984-01-26 | 1988-04-28 | Schering Agrochemicals Limited | Veterinary implants comprising melatonin and derivatives thereof |
GB8508173D0 (en) * | 1985-03-28 | 1985-05-01 | Standard Telephones Cables Ltd | Controlled delivery device |
US4786501A (en) * | 1985-07-15 | 1988-11-22 | International Minerals & Chemical Corp. | Cylindrical implants for the controlled release of growth hormones |
US4765980A (en) * | 1986-04-28 | 1988-08-23 | International Minerals & Chemical Corp. | Stabilized porcine growth hormone |
EP0270575A4 (en) * | 1986-05-16 | 1988-10-20 | Victoria State | BIO-COMPATIBLE IMPLANTS. |
AU601736B2 (en) * | 1986-05-23 | 1990-09-20 | Sanofi Sante Nutrition Animale Sa | Coated veterinary implants |
US4761289A (en) * | 1986-10-10 | 1988-08-02 | International Minerals & Chemical Corp. | Sustained release implant and method for preparing same |
US4863736A (en) * | 1987-03-16 | 1989-09-05 | Monsanto Company | Somatotropin prolonged release |
US4891223A (en) * | 1987-09-03 | 1990-01-02 | Air Products And Chemicals, Inc. | Controlled release delivery coating formulation for bioactive substances |
US4837033A (en) * | 1987-12-22 | 1989-06-06 | Shin-Etsu Chemical Co., Ltd. | Method for the preparation of a coated solid medicament |
-
1990
- 1990-06-20 US US07/541,114 patent/US5091185A/en not_active Expired - Lifetime
-
1991
- 1991-06-17 AT AT91870097T patent/ATE132745T1/de not_active IP Right Cessation
- 1991-06-17 DE DE69116241T patent/DE69116241D1/de not_active Expired - Lifetime
- 1991-06-17 EP EP91870097A patent/EP0462959B1/en not_active Expired - Lifetime
- 1991-06-19 CA CA002044979A patent/CA2044979A1/en not_active Abandoned
- 1991-06-19 KR KR1019910010205A patent/KR940000002B1/ko not_active IP Right Cessation
- 1991-06-19 PT PT98025A patent/PT98025A/pt not_active Application Discontinuation
- 1991-06-19 IE IE210391A patent/IE77161B1/en not_active IP Right Cessation
- 1991-06-19 JP JP3147196A patent/JPH0753659B2/ja not_active Expired - Fee Related
- 1991-06-19 BR BR919102559A patent/BR9102559A/pt not_active Application Discontinuation
- 1991-06-19 AU AU79120/91A patent/AU633741B2/en not_active Ceased
- 1991-06-19 NZ NZ238612A patent/NZ238612A/en unknown
- 1991-06-19 IL IL9855891A patent/IL98558A/en not_active IP Right Cessation
- 1991-06-19 ZA ZA914720A patent/ZA914720B/xx unknown
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20020031241A (ko) * | 2000-10-23 | 2002-05-01 | 유종구 | 패각류를 이용한 알칼리성 칼슘 제조방법 |
Also Published As
Publication number | Publication date |
---|---|
IE77161B1 (en) | 1997-12-03 |
KR940000002B1 (ko) | 1994-01-05 |
IL98558A (en) | 1995-11-27 |
NZ238612A (en) | 1992-10-28 |
JPH0753659B2 (ja) | 1995-06-07 |
US5091185A (en) | 1992-02-25 |
IE912103A1 (en) | 1992-01-01 |
EP0462959B1 (en) | 1996-01-10 |
ATE132745T1 (de) | 1996-01-15 |
DE69116241D1 (de) | 1996-02-22 |
PT98025A (pt) | 1992-06-30 |
BR9102559A (pt) | 1992-01-21 |
AU7912091A (en) | 1992-01-02 |
ZA914720B (en) | 1992-06-24 |
IL98558A0 (en) | 1992-07-15 |
JPH04230210A (ja) | 1992-08-19 |
AU633741B2 (en) | 1993-02-04 |
CA2044979A1 (en) | 1991-12-21 |
EP0462959A1 (en) | 1991-12-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR920000310A (ko) | 코팅된 수의 이식정 | |
US3991750A (en) | Dromostanolone propionate implant pellet useful for producing weight gains in animals and suppressing estrus in female animals | |
US4096239A (en) | Inert core implant pellet | |
US4180560A (en) | Inert core implant pellet | |
US3655864A (en) | Glyceryl tristerate and higher fatty acid mixture for improving digestive absorption | |
US4166107A (en) | Sustained release bolus formulations containing insect growth regulators for control of livestock pests | |
KR100832636B1 (ko) | 동물의 성장을 조절하는 조성물, 이들의 제조 및 사용 방법 | |
US4861586A (en) | Animal bait | |
KR890012668A (ko) | 소마토트로핀을 지속적으로 분비시키는 방법 | |
IE59684B1 (en) | Controlled release delivery system for macromolecules | |
NZ222883A (en) | Animal growth promotion using a steroid and a beta-adrenergic agent | |
US5015627A (en) | Stabilized somatotropin for parenteral administration | |
Rothen-Weinhold et al. | Formulation and technology aspects of conrolled drug delivery in animals | |
CS238353B2 (en) | Device inserted into ruminant's belly | |
US5156851A (en) | Coated veterinary implants | |
Cardinal | Controlled drug delivery: veterinary applications | |
EP1667678B1 (en) | Animal feed composition | |
US5232708A (en) | Coated veterinary implants | |
US3428729A (en) | Controlled release formulation | |
TH10319B (th) | ยาฝังทางสัตว์แพทย์ชนิดเคลือบ | |
TH15777A (th) | ยาฝังทางสัตว์แพทย์ชนิดเคลือบ | |
EP0807430B1 (en) | Medicinal speciality for controlling the birth-rate of birds, and a method for its manufacture | |
ZA202305770B (en) | Long-acting combined agent for expelling and killing ectoparasites in livestock and poultry | |
Tart | Fertility control in captive whitetailed does via GnRH agonist or prostaglandin F2p | |
TH48412A3 (th) | องค์ประกอบสารกระตุ้นการเจริญเติบโต ที่ได้รับการปรับปรุง |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
G160 | Decision to publish patent application | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20041228 Year of fee payment: 12 |
|
LAPS | Lapse due to unpaid annual fee |